News provided by
Share this article
Share this article
This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global pulse oximeters, spirometers market will grow from $4.84 billion in 2022 to $4.95 billion in 2023 at a compound annual growth rate (CAGR) of 2.2%. The pulse oximeters, spirometers market is expected to grow to $5.43 billion in 2027 at a CAGR of 2.3%. Major players in pulse oximeters and spirometers the market are Smiths Medical Inc., Koninklijke Philips N.V., Vyaire Medical, Schiller AG, General Electric Company, Masimo Corporation, Medtronic PLC, Opto Circuits Limited, Fukuda Sangyo Co. Ltd, and Hill-Rom Holdings, Inc.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates. Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market. Measure the impact of high global inflation on market growth. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market. Understand customers based on the latest market shares. Benchmark performance against key competitors. Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The pulse oximeters, spirometers market consists of sales of Handheld, Fingertip, and other pulse oximeters, spirometers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. Pulse oximeters, spirometers used in the diagnosis of respiratory diseases. A pulse oximeter is a non-invasive medical device that is used to monitor the amount of oxygen carried in the body. Spirometer is an apparatus used to measure the volume of air inhaled and exhaled by the lungs and the rate of exhalation. North America was the largest region in the pulse oximeters and spirometers market in 2022. Asia Pacific was the second largest region in the pulse oximeters and spirometers market. The regions covered in the pulse oximeters and spirometers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The main types of pulse oximeters and spirometers are pulse oximeters and spirometers. The pulse oximeters are medical devices that are used to monitor the oxygen saturation levels of blood and pulse rate. The pulse oximeters and spirometers offer applications such as diagnostic and treatment monitoring that are used by various end-users such as hospitals, home care settings, clinical laboratories, and industrial settings. COVID-19 infection is a respiratory illness and therefore there is an increased demand for respiratory devices including pulse oximeters and spirometers. Oxygen therapy is a major intervention for patients with severe COVID-19 infection, and the healthcare providers need to ensure the availability of pulse oximeters and other medical oxygen systems. The market for these devices is expected to surge as they contribute to the early detection and remote monitoring of patients. Increasing incidence of Chronic Obtrusive Pulmonary Disease (COPD) globally due to an increase in aged population over 65 years of age, air pollution, and high smoking prevalence are expected to contribute to the market growth of pulse oximeters and spirometers. There will be a five-fold increased risk for COPD among the population over 65 years than the population below 40 years. Smoking and air pollution damage the lungs, which increases the risk for COPD. Indoor air pollution increases the risk of COPD by 2.65% and smoking by 90%. In 2020, globally there were 1 billion persons aged 65 years or over and it is expected to double in the forthcoming decades. Around 19% of adults smoke tobacco globally and 91% of the population reside in areas where air quality levels exceed WHO limits. Therefore, the increased prevalence of COPD among the population will increase the demand for medical equipment like pulse oximeters and spirometers for diagnosis and therapy maintenance, thus driving the market during the period. Lack of awareness among the global population about respiratory signs and symptoms has hindered the growth of the market. For instance, in according to a research study published on npj Primary care respiratory medicine, the COPD awareness among the respondents from India was less than 1%. Therefore, lack of awareness has a negative impact on the pulse oximeters and spirometers market growth. Companies in the pulse oximeters and spirometer market are increasingly focusing on developing smart and wireless oximeters and spirometers. The use of wireless technology in monitoring devices is trending nowadays, which enhances its ease of usage and data analysis. The integration of wireless technology allows the transfer of data from the device to a smartphone or a wireless device through Bluetooth or cellular connection for data processing and then to display the results. In 2020, Masimo, an American manufacturer of noninvasive patient monitoring technologies, received the first FDA clearance for a fingertip pulse oximeter that can measure respiration rate. In addition, the device will also measure oxygen saturation, pulse rate, perfusion index, and Masimo's Pleth Variability Index (PVi). The countries included in pulse oximeters and spirometers are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. Key Topics Covered:
3. Pulse Oximeters and Spirometers Market Trends And Strategies
4. Pulse Oximeters and Spirometers Market - Macro Economic Scenario
4.1 COVID-19 Impact On Pulse Oximeters and Spirometers Market
4.2 Ukraine-Russia War Impact On Pulse Oximeters and Spirometers Market
4.3 Impact Of High Inflation On Pulse Oximeters and Spirometers Market
5. Pulse Oximeters and Spirometers Market Size And Growth
5.1. Global Pulse Oximeters and Spirometers Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Pulse Oximeters and Spirometers Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Pulse Oximeters and Spirometers Market Segmentation
6.1. Global Pulse Oximeters and Spirometers Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Pulse Oximeters
Spirometers
6.2. Global Pulse Oximeters and Spirometers Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Industrial settings
6.3. Global Pulse Oximeters and Spirometers Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Diagnostic
7. Pulse Oximeters and Spirometers Market Regional And Country Analysis
7.1. Global Pulse Oximeters and Spirometers Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Pulse Oximeters and Spirometers Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/e9cbyb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact:

Global Pulse Oximeters, Spirometers Market Report 2023: Major Players Include Smiths Medical, Koninklijke Philips, Vyaire Medical, Schiller, General Electric and Masimo

Major players in the anesthesia disposables market are Ambu A/S, Medline Industries Inc, Smiths Medical, Teleflex Inc, Vyaire Medical Inc, Armstrong Medical Ltd, Hamilton Medical AG, Intersurgical Ltd, Medtronic Plc, and Mercury Medical. February 10, 2023 07:06 ET
Lyon,  FRANCE
New York, Feb.  10, 2023  (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Anesthesia Disposables Global Market Report 2023" - https://www.reportlinker.com/p06277216/?utm_source=GNW
The global anesthesia disposables market will grow from $1 billion in 2022 to $1.06 billion in 2023 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The anesthesia disposables market is expected to grow to $1.3 billion in 2027 at a CAGR of 5.2%. The anesthesia disposables market consists of sales of instruments such as anesthesia circuits, anesthesia masks, sample lines, filters/Heat & Moisture Exchangers (HMEs), breathing bag, endotracheal tubes, and laryngeal masks.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. Anesthesia medication is used to cause a temporary loss of sensation in patients. Anesthesia disposables are the single-use, portable, and easy-to-use devices that prevent the risk of infections in patients. Asia Pacific was the largest region in the anesthesia disposables market in 2022.Western Europe was the second-largest region in the anesthesia disposables market. The regions covered in the anesthesia disposables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The main products of anesthesia disposables are anesthesia breathing circuits, endotracheal tubes, anesthesia gas masks, and laryngeal mask airway.Laryngeal mask airways (LMA) are supraglottic devices that are used as a temporary method to maintain an open airway during the administration of anesthesia or as an immediate life-saving measure in a patient with a difficult or failed airway. The patient groups are neonatal, adult, and pediatric. The various end-users are hospitals, clinics, home care settings, and other end users. The increase in the aging population leads to increased surgeries driving the anesthesia disposable market.Increasing life expectancies paired with age-related comorbidities have resulted in the growth of the elderly population who undergo surgeries. The prevalence of cardiovascular disease, arthritis, thyroid disease, and emphysema is steadily increasing, which is proportionally increasing the number of surgeries coupled with the growing prevalence of diseases. These diseases are found mainly in elderly people, which is increasing the consumption of anesthesia disposables as they are widely used in surgical procedures and are driving the market in the forecast period. Lack of trained anesthesiologists is restraining the market.Anesthetist plays a very vital role in patient’s care during and posts any surgery or operation. They acquire the ability to offer a premium level of care to their patients.As with the increase in the number of patients especially for surgery and operations across the globe, the demand for skilled and trained anesthetists also increases. To meet rising patient demand for anesthesia services, countries are facing a critical shortage of skilled and trained anesthetists.For example, the Centre for Workforce Intelligence, a unit of UK NHS staffing agency Health Education England stated that according to their study, the demand for anesthetic services would grow by 25% by 2033, and would require the number of anesthetists to grow by 300 a year. As reported in a study conducted by the American Association of Medical Colleges (AAMC), a shortfall of 33,800 to 72,700 physicians across the specialties is expected by 2030. Thus there is a significant gap in the requirement of trained anesthesiologists across the country which is likely to hinder the growth of the anesthesia disposables market. The demand for cuffed endotracheal tubes (ETTs) in pediatrics is growing as compared to uncuffed ETTs.During pediatric anesthesia, general endotracheal intubation is commonly performed for airway management and positive pressure ventilation. Traditionally, uncuffed endotracheal tubes (ETTs) are recommended for children up to eight years old.But the major disadvantages of the uncuffed ETTs such as an increase in air leakage around the tube, make it difficult to ensure that the child is breathing adequate amounts of oxygen. In addition, the measurement of tidal volume is also compromised.Uncuffed ETTs also allow waste anesthetic gases to escape, contributing significantly to operating room contamination and rendering the anesthetic procedure more expensive. Therefore, the trend is towards increasing the usage of cuffed ETTs for pediatric procedures. According to the American Association of Nurse Anesthetists, facilities should select disposables registered with the U.S. Environmental Protection Agency (EPA) and follow manufacturer recommendations regarding use, exposure time, and disposal. Also, they should discard disposable single-use devices in a biohazardous bag/container (e.g., breathing circuits, airway devices, orogastric tubes) immediately after use. The countries covered in the anesthesia disposables market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified). The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products. The anesthesia disposables market research report is one of a series of new reports that provides anesthesia disposables market statistics, including anesthesia disposables industry global market size, regional shares, competitors with a anesthesia disposables market share, detailed anesthesia disposables market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia disposables industry. This anesthesia disposables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anesthesia Disposables Global Market Report 2023

News provided by
Share this article
Current and future market trends to highlight market conditions
Comparative analysis of the market and its segments for the historic period of 2017 - 2021
Market drivers and market impediments and their impact on market growth
Positioning of market players and their business strategy analysis
Polysomnography devices market Size & Segmentation Analysis
The polysomnography devices market is estimated to grow at a CAGR of 6.55% between 2022 and 2027. The size of the market is forecast to increase by USD 171.76 million. The polysomnography devices market is segmented based on application, type, and geography. Based on application, the polysomnography devices market is segmented into hospitals, sleep clinics and diagnostic laboratories, ASCs, and homecare. Based on type, the market is segmented into ambulatory polysomnography devices and clinical polysomnography devices. Based on geography, the polysomnography devices market is segmented into North America, Europe, Asia, and Rest of World. For insights on the market contribution of each segment,  Buy the report! Polysomnography devices market: Country-Level Analysis
The countries covered in the polysomnography devices market report are the US and Canada (North America); the UK, Germany, France, and the Rest of Europe (Europe); China, India, Vietnam, and others (Asia); Saudi Arabia, South Africa, Brazil, and others (Rest of World). North America will account for 39% of the market growth during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The growth in North America can be attributed to several factors, including the increasing prevalence of sleep apnea, including OSA. The number of people affected by obesity has increased at an alarming rate in the US over the past two decades. In 2021, around 42% of US adults were obese. The obese population suffers from breathing problems while sleeping due to the high deposition of fat in the airway passage, which leads to OSA. In addition, the region is home to several prominent vendors including Natus Medical Inc. (Natus Medical), Cadwell Industries, ResMed, Neurovirtual, Cleveland Medical Devices Inc. (Cleveland Medical Devices), and Vyaire Medical Inc. (Vyaire Medical). These factors are driving the growth of the polysomnography market in North America. The geographic landscape of the report also provides market-impacting factors and changes that impact current and future trends. For detailed information, Request a sample! Polysomnography devices market: Dynamics & Insights
Technavio's research report on polysomnography devices market  provides analysis and insights about the various drivers, along with key challenges, that impact the market throughout the forecast period. The benefits of polysomnography are notably driving market growth. Polysomnography test is non-invasive and causes little to no discomfort and pain to the patient. It records the brain wave activity, heart rate, blood oxygen levels, and breathing when the patient is asleep and detects any disruptions to help doctors diagnose sleep abnormalities and formulate a targeted treatment plan. The test is recommended for patients having sleep disorders, such as sleep apnea, narcolepsy, REM sleep, and chronic insomnia. With advances in technology, vendors in the market are introducing portable monitoring devices that allow patients to analyze sleep patterns at home. For instance, SOMNOmedics offers full polysomnography systems, such as SOMNOtouch PSG, for use within the home of the patient. All these factors are driving the growth of the global polysomnography devices market. However, the lack of public awareness is a major challenge impeding the market. Many people have the least awareness of sleeping disorders and their management and treatment. Besides, the global healthcare system does not have enough medical laboratory technologists to meet the increasing demands of healthcare. The healthcare industry is facing a gradual rise in the shortage of skilled lab technicians. Thus, the lack of public awareness and the shortage of medical lab technicians can hinder the growth of the market during the forecast period. Polysomnography devices market: Competitive Landscape and Vendor Analysis
Technavio's report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies. Some of the major players operating in the polysomnography devices market are Advin Health Care, BMC Medical Co. Ltd., Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Ltd., Contec Medical Systems Co. Ltd., Genotronics, Koninklijke Philips NV, Lowenstein Medical Technology GmbH and Co. KG, MEDATEC Medical Data Technology SPRL BVBA, Medicom MTD Ltd, Natus Medical Inc., Neurosoft, Neurovirtual USA, Nihon Kohden Corp., Nox Medical, Recorders and Medicare Systems Pvt Ltd., ResMed Inc., SOMNO medics GmbH, and Vyaire Medical Inc. among others. For insights on the vendor offerings, Download a PDF sample! Related Reports:
The traumatic brain injury assessment and management devices market is estimated to grow at a CAGR of 8.66% between 2022 and 2027. The size of the market is forecast to increase by USD 1,723.41 million. The increasing prevalence of brain surgeries is notably driving the market growth, although factors such as the scarcity of skilled neurologists and neurodiagnostic technicians may impede the market growth. The vital signs monitoring devices market is estimated to grow at a CAGR of 9.13% between 2022 and 2027. The size of the market is forecast to increase by USD 4.79 billion. The growing preference for self-care monitoring devices is notably driving the market growth, although factors such as intense competition among vendors may impede the market growth. Gain instant access to 17,000+ market research reports. Key companies profiled
Advin Health Care, BMC Medical Co. Ltd., Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Ltd., Contec Medical Systems Co. Ltd., Genotronics, Koninklijke Philips NV, Lowenstein Medical Technology GmbH and Co. KG, MEDATEC Medical Data Technology SPRL BVBA, Medicom MTD Ltd, Natus Medical Inc., Neurosoft, Neurovirtual USA, Nihon Kohden Corp., Nox Medical, Recorders and Medicare Systems Pvt Ltd., ResMed Inc., SOMNO medics GmbH, and Vyaire Medical Inc.
Market dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Table of contents:
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
Exhibit 18: Historic Market Size – Data Table on Global polysomnography devices market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021 
Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021 
Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021 
Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
Exhibit 33: Data Table on Comparison by Application
6.3 Hospitals - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
6.4 Sleep clinics and diagnostic laboratories - Market size and forecast 2022-2027 
Exhibit 38: Chart on Sleep clinics and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Sleep clinics and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Sleep clinics and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Sleep clinics and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
6.5 ASCs - Market size and forecast 2022-2027
Exhibit 42: Chart on ASCs - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on ASCs - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on ASCs - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on ASCs - Year-over-year growth 2022-2027 (%)
6.6 Homecare - Market size and forecast 2022-2027
Exhibit 46: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Homecare - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application 
Exhibit 50: Market opportunity by Application ($ million)
7 Market Segmentation by Type
7.1 Market segments 
Exhibit 54: Data Table on Comparison by Type
7.3 Ambulatory polysomnography devices - Market size and forecast 2022-2027 
Exhibit 55: Chart on Ambulatory polysomnography devices - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Ambulatory polysomnography devices - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Ambulatory polysomnography devices - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Ambulatory polysomnography devices - Year-over-year growth 2022-2027 (%)
7.4 Clinical polysomnography devices - Market size and forecast 2022-2027 
Exhibit 59: Chart on Clinical polysomnography devices - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Clinical polysomnography devices - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Clinical polysomnography devices - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Clinical polysomnography devices - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type 
Exhibit 63: Market opportunity by Type ($ million)
8 Customer Landscape
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 101: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography 
Exhibit 105: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts

10:30 ET
Global polysomnography devices market: Driving Factors, Industry Challenges, Segmentation, Key Vendor Analysis, Leading...

Spirometers Market Analysis: Competitive Landscape and Key Developments
Jones Medical Instrument Company; Benson Medical Instruments Co.; NuvoAir AB; Teleflex Incorporated; Vyaire Medical, Inc.; COSMED Srl; Depisteo LLC; Henry Schein, Inc; Baxter International Inc.; and ICU Medical Inc. are among the key companies operating in the spirometers market. The market leaders focus on new product launches, expansion and diversification, and acquisition strategies, which allow them to tap into prevailing business opportunities. Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00018813/
In January 2022, ICU Medical announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of ~US$2.5 billion. In December 2021, Baxter announced the acquisition of Hill-rom, a leading manufacturer of spirometry products. This combination unlocked the next phase of the company's transformation for greater impact on patients, employees, clinicians, and shareholders worldwide. In November 2021, COSMED launched the 2nd generation of OMNIA Software, the most comprehensive data management platform for metabolic, lung function, and body composition assessment. In April 2021, the US FDA cleared NuvoAir's Air Next connected spirometer device. According to the FDA’s premarket notification database, the Stockholm, Sweden-based company submitted its application in November 2018. In February 2020, COSMED acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for hemodynamic (cardiac output), ventilation heterogeneity (lung clearance index), and metabolic measurements (VO2Max). In August 2019, Hill-rom entered a definitive agreement to acquire Breathe Technologies, Inc., developer and manufacturer of a patented wearable, noninvasive ventilation technology that supports improved patient mobility, for a cash consideration of US$130 million. North America dominated the spirometers market in 2021. The market in the region is expected to grow in the coming years due to the rising prevalence of respiratory disorders and the increasing number of product launches by market players. The growth of the US spirometer market is attributed to the rise in the prevalence of respiratory diseases due to the increasing incidence of smoking among people. According to the CDC, ~40 million adults in the US smoke cigarettes, and around 4.7 million middle and high school students use at least one tobacco product, including e-cigarettes. Moreover, every day, around 1,600 US youth younger than 18 years smoke their first cigarette. In addition, the FDA approvals for spirometers are rising for early detection of respiratory disorders. For instance, in January 2020, the US FDA cleared NuvoAir's connected spirometer device. Thus, these factors are expected to bolster the spirometer market growth across the US in the coming years. Have a question? Speak to Research Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00018813
Spirometers Market: Impact of COVID-19 Pandemic
There has been a rising demand for spirometers amid the COVID-19 pandemic. The spirometer market has a highly technological and advanced research industry. The spirometer market witnessed a positive impact during the pandemic due to increased demand for COVID-19 spirometers. Patients suffering from COPD, pneumonia, acute chest syndrome, and other similar respiratory disorders often use an incentive spirometer. Researchers at the University of Illinois at Chicago suggested the use of an incentive spirometer for the treatment of COVID-19 patients suffering from mild to moderate respiratory symptoms, according to a research report published by the American Journal of Emergency Medicine in January 2021. Therefore, the adoption of spirometers is increasing during the pandemic. Thus, the market has witnessed a positive impact post the first wave of the COVID-19 outbreak. Rising Prevalence of Respiratory Diseases Influences Overall Market Growth
The higher prevalence of respiratory disorders is related to the decrease in the size of the upper airway lumen in the aging population. Lung diseases are among the most common medical conditions across the world. Further, millions of people are suffering from various types of respiratory diseases. Moreover, smoking, genetic factors, and infections are among the common factors responsible for respiratory diseases. Medical conditions, including asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, and lung cancer, are significant public health burdens. Patients suffering from respiratory disorders commonly experience difficulty in breathing. Further, early detection and diagnosis can help in treating patients suffering from respiratory diseases. To treat these patients, spirometry is a crucial technology that assists in indulging in the severity of the infection and avoids misdiagnosis. Thus, the increasing incidence of respiratory diseases drives the growth of the market. Avail Lucrative DISCOUNTS on “Spirometers Market” Research Study: https://www.theinsightpartners.com/discount/TIPRE00018813/
Spirometers Market: Segmental Overview
Based on type, the spirometer market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment holds the largest market share in 2022. However, the handheld segment is anticipated to register the highest CAGR during the forecast period as the small, lightweight, and easily portable handheld spirometers are becoming universal in the industry. Based on technology, the spirometer market is segmented into volume, flow, and peak flow. In 2022, the flow segment holds the largest market share. However, the peak flow segment is expected to register the highest CAGR from 2022 to 2028, due to its working pattern as patients blow into a mouthpiece at one end of the device, and the peak flow meter measures the force of the air flowing out of the lungs in liters per minute. Based on application, the spirometer market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. In 2022, the chronic obstructive pulmonary disease segment holds the largest share of the market. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028, owing to the growing prevalence of COPD and the adoption of easy diagnosis of COPD offered by spirometry. Directly Purchase Premium Copy of Spirometers Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPRE00018813/
Browse Adjoining Reports:  
Spirometer Transducers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Turbine Sensor, Temperature Sensor); Application (Hospitals, Clinics, Others) and Geography
Respiratory Measurement Devices Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Pulse Oximetry Systems, Spirometers, Peak Flow Meters, Capnographs); Indication (COPD, Asthma, Bronchitis, Others); End User (Hospitals and Clinics, Ambulatory Surgical Care Centers, Homecare Settings, Others) and Geography
Respiratory Monitoring Devices Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Spirometer, Pulse Oximeter, Peak Flow Meter, and Capnographs), End User (Hospitals, and Home Care) and Geography
Pulmonary Pressure Monitors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Coverage : Product Type (Oximeters, Capnographs, and Spirometers); Application (Respiratory Disorders, Glaucoma, Cardiac Disorder, Neurological Disorder, Dialysis, and Others); Procedures (Invasive, Non-invasive); End-user (Hospitals, Homecare settings, Ambulatory Surgical Centers, Clinics, Diagnostics Laboratories, and Others)
Respiratory Care Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product {Therapeutic Devices [Positive Airway Pressure (PAP) Devices (CPAP Devices, APAP Devices, and BiPAP Devices), Oxygen Concentrators (Fixed Oxygen Concentrators and Portable Oxygen Concentrators), Ventilators, Inhalers (Metered Dose Inhalers and Dry Powder Inhalers), Nebulizers, Humidifiers, and Others], Monitoring Devices (Pulse Oximeters, Capnography, and Gas Analyzers), Diagnostic Devices (Spirometers, Polysomnography Devices, Peak Flow Meters, and Other Diagnostic Devices), and Consumables & Accessories (Masks, Disposable Resuscitators, Tracheostomy Tubes, Breathing Circuits, and Other Consumables & Accessories)}, Indication [Chronic Obstructive Pulmonary Diseases (COPD), Sleep Apnea, Asthma, Infectious Diseases, and Others], and End User (Hospitals, Home Care, and Ambulatory Care)
Positive Airway Pressure (PAP) Devices Market to 2027 - Global Analysis and Forecasts By Product (Automatic Positive Airway Pressure (APAP) Devices, Continuous Positive Airway Pressure (CPAP) Devices, Bilevel Positive Airway Pressure (BPAP) Devices); End User (Sleep Laboratories & Hospitals, Home Care/Individuals) and Geography
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi

Spirometers Market Size Worth $1,907.36 million Globally, by 2028 at 11.5% CAGR - Exclusive Report by The Insight Partners

Medtech companies have orchestrated many noteworthy portfolio moves in recent years, creating interesting market dynamics. Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors06.01.22
Medtech companies have orchestrated many noteworthy portfolio moves in recent years. Specialty acquisition corporations (SPACs), M&As, and divestitures (the sale or “spinoff” of a business unit) are creating interesting market dynamics. However, these events can have a significant impact on OEM suppliers. M&A activity naturally leads to some industry consolidation (fewer players in key market sectors), which in turn, creates performance pressure for OEM suppliers as larger merged companies whittle down their approved vendor lists. SPACs are interesting because they come in many flavors. In some cases, a SPAC is the result of a private company turning public but in other cases, it is spawned from a merger (or a reverse merger, technically). One recent example of a medtech industry SPAC is Corza Medical , which was created last winter from the combination of Surgical Specialties Corporation and the TachoSil Fibrin Sealant Patch. In December 2021, Corza Medical acquired Katena Products Inc., a Parsippany, N.J.-based company focused on ophthalmic surgery devices. Divestitures also help expand the industry, as these transactions typically free up new capital to support the newly-created independent company that has been separated from its “mother” conglomerate. But if the divestiture is simply a sale of a business unit from one conglomerate to another, it’s less impactful. Using data from Mergr, we’ve analyzed the portfolio moves by some of the Top 30 medtech companies and their resulting impact(s) on OEM suppliers. Medtronic: The world’s largest medical device firm has acquired 58 companies, including 12 in the past five years. That’s a lot of acquisitions. It has also divested four assests via sales to other companies. Last summer, Medtronic bought Intersect ENT for $1.1 billion. As is typical with most acquisitions nowadays, Medtronic’s supply chain professionals immediately went to work once the deal was complete to figure out how to consolidate vendors between the two companies. Johnson & Johnson: With 57 M&A deals (40 purchases and 17 entities sold), the New Brunswick, N.J.-headquartered firm has been a very lively manager of its portfolio across all business segments. Most recently, J&J announced plans to spin off its $15 billion consumer health business in 2023 (at a cost of $500 million to $1 billion). The move will likely help J&J’s current medtech suppliers, since the company will have more capital to spend on its current medical devices and pharmaceutical business activities. Abbott: The medical device/healthcare conglomerate has also been very active by participating in 33 acquisitions and eight divestitures, including some major multi billion-dollar purchases and sales in recent years—i.e., selling Abbott Medical Optics to J&J in 2017, and purchasing both St. Jude Medical Inc. ($25 billion) and Alere Inc. ($5.3 billion). The recent parting of Abbott’s STARLIMS informatics suite (and related businesses) to global investment firm Francisco Partners should be healthy for STARLIMS’ growth and its vendors’ expansion as well. Philips: Twenty years ago, Royal Philips was a multi-faceted conglomerate with interests across various industries, including Domestic Appliances and Lighting. But through a flurry of M&A moves (33 purchases and 13 sales), Philips is now a highly focused top-tier medical device manufacturer. Last spring, Philips shed its Domestic Appliances business, selling it to Hillhouse Capital for $4.4 billion, and in November 2021, the company expanded its cardiac diagnostics and monitoring portfolio by purchasing Cardiologs. Unfortunately, some of Philips’ other purchases have injected some instability in its supply chain, but that’s fodder for a different column. GE Healthcare: Facing pressure from competitors like Siemens Healthineers, GE has responded by engaging in both M&A and strategic partnerships. While it has purchased 27 companies and sold 11, GE Healthcare has also been forging alliances to bolster its competitive edge. For example, after Siemens Healthineers bought Varian Medical Systems Inc. for $16.4 billion (August 2020), GE Healthcare partnered with Elekta (Varian’s major competitor) to expand access to precision radiation therapy solutions. BD: This major conglomerate has significantly reshaped its portfolio over the last five years through M&A, starting with the $24 billion purchase of C.R. Bard Inc. in 2017. Besides dynamically changing the shape of the company, the acquisition also likely put pressure on smaller OEM vendors to become a “one-stop shop” to help their customers save time and money. Separately, BD’s 2018 divestiture of Vyaire Medical to private equity firm Apax Partners created new opportunities (with fresh capital) for Vyaire suppliers. Additionally, the recent IPO spinoff of BD’s $1 billion diabetes care business unit creates new opportunities for investment into the company’s diabetes products and will be helpful to OEM suppliers serving this segment. Siemens Healthineers: This company was created through an IPO spinoff from Siemens AG in 2018, generating fresh capital for investment in the medtech industry and benefitting all current and potential Healthineers suppliers. Siemens Healthineers’ 2020 acquisition of Varian Medical Systems would never have occurred if Siemens did not spin off its healthcare business. Cardinal Health: With 48 M&A transactions (39 purchases and nine divestitures), Cardinal Health is another vigorous manager of its business unit portfolio. Although it is constantly under pressure due to its lower-than-industry-standard margins, Cardinal is actively acquiring and purging its businesses to improve the mother ship. Its relatively low margin performances puts pressure on OEM suppliers on a continuous basis. The company’s 2021 divestiture of its Cordis business to private equity firm Hellman & Friedman is allowing for fresh capital in Cordis’ products, which should create new opportunities for suppliers. Stryker Corp.: Averaging more than two acquisitions per year, Stryker—with a total of 39 purchases and four sales—is one of the most energetic M&A players in medtech. The company’s $3 billion acquisition of Vocera Communications in February should beget new opportunities for its OEM suppliers as new market segments and product opportunities are created. An acquisition that likely forced some of Stryker’s vendors into some forms of synergies (i.e., consolidation) was the $4 billion purchase of Wright Medical Group in 2019. Baxter International: This Deerfield, Ill.-based firm most recently transformed itself through M&A—specifically, last year’s $10.5 billion acquisition of Hillrom. Until that time, most of Baxter’s transactions were incremental “add-on” deals targeting its core market segments. The Hillrom purchase dramatically changes the market segments and opportunities within the combined entity. It will be interesting to observe how this merger plays out within Baxter and for its suppliers. In summary, OEM suppliers are highly impacted by these continuous portfolio moves by the medtech industry’s leading players. Smaller companies and suppliers must carefully consider these moves when planning their long-term growth strategies and potential partnerships with OEM customers. Florence Joffroy-Black, CM&AA, is a longtime marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She currently is CEO at MedWorld Advisors and can be reached at florencejblack@medworldadvisors.com or at www.medworldadvisors.com . Dave Sheppard, CM&AA, is a former medical technology Fortune 500 executive and is now focused on M&A as a managing director at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com . Related Content

The Impacts of SPACs, M&A, and Divestitures on OEM Suppliers

Genworks is dedicated to improving healthcare access in India by delivering better medical facilities and diagnostics while keeping healthcare affordable. It is providing relevant and affordable technology to providers in India and therefore improving clinical outcomes. The company was founded in 2015 and is based in Bangalore, India.

Genworks

In May , Vyaire Medical , a global company focused exclusively on supporting breathing through every stage of life , entered into an agreement with GenWorks Health , a healthcare solutions provider with 140 locations within India and a direct presence in 27 states .

Follow us on Facebook
Follow us on LinkedIn
Follow us on Instagram
Vyaire Medical Expands Presence in India with GenWorks Deal.

Automated develops interpretations of pulmonary function tests. It is producing a standardized evaluation of a patient's lung function.

ArtiQ

The Commission represents and upholds the interests of the EU as a whole, and is independent of national governments. It is headed by 28 Commissioners, one per EU country. The European Commission prepares legislation for adoption by the Council (representing the member countries) and the Parliament (representing the citizens). It administers the budget and the policy programmes (Agriculture, Fisheries, Research etc.) in cooperation with authorities in the member countries.

European Commission

Spirit AeroSystems is a producer of large aerostructures and components of the world's premier aircraft. Spirit AeroSystems designs and builds aerostructures for both commercial and defense customers. With headquarters in Wichita, Kansas, Spirit operates sites in North America, Europe, and Asia.

Spirit AeroSystems

Acelity

Smith & Nephew

GE Healthcare

GEO Specialty Chemicals

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Medical Devices

Conference Exhibitors

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

Health Monitoring & Diagnostics

Health IT 

Steven  Dyson

Arthur  Brothag

Private Equity

Acq - Fin

Vyaire Medical is a global medical device company and unified "breathing company," specializing in the respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring market segments.

Wells Fargo Success Story

Professional Services

Platform Overview

Vyaire Medical

Vyaire Medical’s Customers

Compete with Vyaire Medical?

Compete with Vyaire Medical?

Discover the right solution for your team